Literature DB >> 25028566

Transcriptional regulation of human hydroxysteroid sulfotransferase SULT2A1 by LXRα.

Zhimin Ou1, Mengxi Jiang1, Bingfang Hu1, Yixian Huang1, Meishu Xu1, Songrong Ren1, Song Li1, Suhuan Liu2, Wen Xie2, Min Huang2.   

Abstract

The nuclear receptor liver X receptor (LXR) plays an important role in the metabolism and homeostasis of cholesterol, lipids, bile acids, and steroid hormones. In this study, we uncovered a function of LXRα (NR1H3) in regulating the human hydroxysteroid sulfotransferase SULT2A1, a phase II conjugating enzyme known to sulfonate bile acids, hydroxysteroid dehydroepiandrosterone, and related androgens. We showed that activation of LXR induced the expression of SULT2A1 at mRNA, protein, and enzymatic levels. A combination of promoter reporter gene and chromatin immunoprecipitation assays showed that LXRα transactivated the SULT2A1 gene promoter through its specific binding to the -500- to -258-base pair region of the SULT2A1 gene promoter. LXR small interfering RNA knockdown experiments suggested that LXRα, but not LXRβ, played a dominant role in regulating SULT2A1. In primary human hepatocytes, we found a positive correlation between the expression of SULT2A1 and LXRα, which further supported the regulation of SULT2A1 by LXRα. In summary, our results established human SULT2A1 as a novel LXRα target gene. The expression of LXRα is a potential predictor for the expression of SULT2A1 in human liver.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25028566      PMCID: PMC4164974          DOI: 10.1124/dmd.114.058479

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  32 in total

1.  Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.

Authors:  Jon L Collins; Adam M Fivush; Michael A Watson; Cristin M Galardi; Michael C Lewis; Linda B Moore; Derek J Parks; Joan G Wilson; Tim K Tippin; Jane G Binz; Kelli D Plunket; Daniel G Morgan; Elizabeth J Beaudet; Karl D Whitney; Steven A Kliewer; Timothy M Willson
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

Review 2.  The liver X receptor gene team: potential new players in atherosclerosis.

Authors:  Joyce J Repa; David J Mangelsdorf
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 3.  Liver X receptor signaling pathways in cardiovascular disease.

Authors:  Peter Tontonoz; David J Mangelsdorf
Journal:  Mol Endocrinol       Date:  2003-04-10

4.  Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.

Authors:  Hirdesh Uppal; Simrat P S Saini; Antonio Moschetta; Ying Mu; Jie Zhou; Haibiao Gong; Yonggong Zhai; Songrong Ren; George K Michalopoulos; David J Mangelsdorf; Wen Xie
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

Review 5.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

6.  An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.

Authors:  B A Janowski; P J Willy; T R Devi; J R Falck; D J Mangelsdorf
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

Review 7.  Enzymology of human cytosolic sulfotransferases.

Authors:  C N Falany
Journal:  FASEB J       Date:  1997-03       Impact factor: 5.191

8.  Androgen deprivation by activating the liver X receptor.

Authors:  Jung Hoon Lee; Haibiao Gong; Shaheen Khadem; Yi Lu; Xiang Gao; Song Li; Jian Zhang; Wen Xie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  LXR-dependent gene expression is important for macrophage survival and the innate immune response.

Authors:  Sean B Joseph; Michelle N Bradley; Antonio Castrillo; Kevin W Bruhn; Puiying A Mak; Liming Pei; John Hogenesch; Ryan M O'connell; Genhong Cheng; Enrique Saez; Jeffery F Miller; Peter Tontonoz
Journal:  Cell       Date:  2004-10-15       Impact factor: 41.582

10.  Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.

Authors:  Hirdesh Uppal; Yonggong Zhai; Archana Gangopadhyay; Shaheen Khadem; Songrong Ren; James A Moser; Wen Xie
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

View more
  3 in total

1.  Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.

Authors:  Elizabeth A Rondini; Asmita Pant; Thomas A Kocarek
Journal:  J Pharmacol Exp Ther       Date:  2015-10-01       Impact factor: 4.030

2.  Chronic Activation of Liver X Receptor Sensitizes Mice to High Cholesterol Diet-Induced Gut Toxicity.

Authors:  Wojciech G Garbacz; Hirdesh Uppal; Jiong Yan; Meishu Xu; Songrong Ren; Donna B Stolz; Min Huang; Wen Xie
Journal:  Mol Pharmacol       Date:  2018-07-25       Impact factor: 4.436

Review 3.  Uncovering drug-responsive regulatory elements.

Authors:  Marcelo R Luizon; Nadav Ahituv
Journal:  Pharmacogenomics       Date:  2015-11-10       Impact factor: 2.533

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.